Patrick Keran
Plus aucun poste en cours
Fortune : 1 M $ au 30/04/2024
Profil
Patrick L.
Keran worked as an Associate General Counsel at Ionis Pharmaceuticals, Inc. from 2004 to 2006.
He then served as the President, Chief Operating Officer & Secretary at Mast Therapeutics, Inc. from 2013 to 2015.
From 2015 to 2023, he worked as the Secretary, Senior Vice President & General Counsel at SeaSpine Holdings Corp.
In 2023, he will work as the Chief Legal Officer at Naia Pharmaceuticals, Inc. Keran received his undergraduate degree from the University of California San Diego and his graduate degree from Berkeley Law University of California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ORTHOFIX MEDICAL, INC.
0,23% | 28/02/2023 | 84 407 ( 0,23% ) | 1 M $ | 30/04/2024 |
Anciens postes connus de Patrick Keran
| Sociétés | Poste | Fin |
|---|---|---|
| ORTHOFIX MEDICAL INC. | Conseiller Juridique Général | 11/09/2023 |
| SEAE HLDG | Conseiller Juridique Général | 05/01/2023 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Directeur Financier/CFO | 02/01/2013 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2006 |
Naia Pharmaceuticals, Inc.
 Naia Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Part of Naia Ltd., Naia Pharmaceuticals, Inc. manufactures biopharmaceutical products. The company is based in San Francisco. | Conseiller Juridique Général | - |
Formation de Patrick Keran
| University of California San Diego | Undergraduate Degree |
| Berkeley Law University of California | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ORTHOFIX MEDICAL INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
SeaSpine Holdings Corp.
 SeaSpine Holdings Corp. Information Technology ServicesTechnology Services SeaSpine Holdings Corp. operates as a medical technology company. The firm engages in the design, developmen and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It products include thoracolumbar hardware, cervical hardware, orthobiologics, and spine pure strip. The company was founded on February 12, 2015 and is headquartered in Carlsbad, CA. | Technology Services |
Naia Pharmaceuticals, Inc.
Naia Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Part of Naia Ltd., Naia Pharmaceuticals, Inc. manufactures biopharmaceutical products. The company is based in San Francisco. | Health Services |
